About Batavia Biosciences
Batavia Biosciences is a company based in Leiden (Netherlands) founded in 2010 by Chris Yallop and Menzo Havenga was acquired by CJ CheilJedang in November 2021.. The company has 11 employees as of December 31, 2021. Batavia Biosciences offers products and services including Viral Vectors, Viral Vaccines, and HIP-Vax Technology. Batavia Biosciences operates in a competitive market with competitors including KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others.
- Headquarter Leiden, Netherlands
- Employees 11 as on 31 Dec, 2021
- Founders Chris Yallop, Menzo Havenga
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Batavia Bio Processing Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$444.29 K (USD), Grant
May 01, 2023
-
Investors
Gates Foundation
& 3 more
-
Employee Count
11
as on Dec 31, 2021
-
Acquired by
CJ CheilJedang
(Nov 08, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Batavia Biosciences
Batavia Biosciences offers a comprehensive portfolio of products and services, including Viral Vectors, Viral Vaccines, and HIP-Vax Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Development and manufacturing for gene therapy and delivery tools.
Process development for vaccine production and applications.
Platform for efficient polio and other vaccine manufacturing processes.
Unlock access to complete
Funding Insights of Batavia Biosciences
- Total Funding Total Funding
- Total Rounds 8
- Last Round Grant — $444,292
-
First Round
First Round
(01 Jun 2016)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Grant - Batavia Biosciences | Valuation |
investors |
|
| Sep, 2019 | Amount | Grant - Batavia Biosciences | Valuation |
investors |
|
| Jul, 2019 | Amount | Grant - Batavia Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Batavia Biosciences
Batavia Biosciences has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Gates Foundation, Path and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Founded Year | Domain | Location | |
|
Global health solutions are developed and delivered to enhance outcomes.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Batavia Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Batavia Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Batavia Biosciences Comparisons
Competitors of Batavia Biosciences
Batavia Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| domain | founded_year | HQ Location |
Biologics development and manufacturing services are offered by EirGenix.
|
|
| domain | founded_year | HQ Location |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for microbiome based diseases
|
|
| domain | founded_year | HQ Location |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| domain | founded_year | HQ Location |
Vaccines and biologics are developed and manufactured by IDT Biologika.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Batavia Biosciences
Frequently Asked Questions about Batavia Biosciences
When was Batavia Biosciences founded?
Batavia Biosciences was founded in 2010 and raised its 1st funding round 6 years after it was founded.
Where is Batavia Biosciences located?
Batavia Biosciences is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.
Who is the current CEO of Batavia Biosciences?
Menzo Havenga is the current CEO of Batavia Biosciences. They have also founded this company.
How many employees does Batavia Biosciences have?
As of Dec 31, 2021, the latest employee count at Batavia Biosciences is 11.
What does Batavia Biosciences do?
Batavia Biosciences is a CDMO engaged in the development of biopharmaceutical products such as proteins, antibodies, vaccines and viral vectors. They have a portfolio of technologies for improving product yield (STEP), to reduce process development time (SIDUS, SCOUT) and for improving product stability. Their STEP technology is a plasmid based expression platform that enables rapid mammalian CHO cell line generation and improved protein expression. Batavia claims that the STEP platform can offer up to 10-fold increase in protein expression and the stable cell clones can be generated in 14 weeks. They also have a transient production technology that can be used for producing clinical material (proteins) faster. The company claims to have expertise in upstream (mammalian, microbial and insect based platforms) and downstream processing, clinical and commercial manufacturing and also in DNA cloning and mammalian cell line generation.
Who are the top competitors of Batavia Biosciences?
Batavia Biosciences's top competitors include KBI Biopharma, Aldevron and Ovagen.
What products or services does Batavia Biosciences offer?
Batavia Biosciences offers Viral Vectors, Viral Vaccines, and HIP-Vax Technology.
Who are Batavia Biosciences's investors?
Batavia Biosciences has 4 investors. Key investors include Gates Foundation, Path, European Union, and CJ CheilJedang.